Dr. Ehtisham “Shami” Mahmud has been appointed Chief of Clinical Cardiovascular Medicine in the Department of Medicine and UC San Diego Health System, Interim Chair Wolfgang Dillmann, MD, has announced.
Mahmud, Professor of Clinical Medicine and a regional and national leader in cardiovascular medicine for more than a decade, is also the Co-Director of the recently-opened Sulpizio Cardiovascular Center at UC San Diego. He has been instrumental in the planning of the Sulpizio Cardiovascular Center, is part of its executive leadership team and is integrally involved in the progammatic development within the Sulpizio Cardiovascular Center.
Mahmud’s new position in the Department of Medicine, which directly reports to the Chair of Medicine, reflects UC San Diego’s increasing focus on the development and delivery of novel diagnostic and therapeutic approaches for the treatment of cardiovascular disease.
In this new position, Mahmud will be responsible for the finances, strategic plans, and faculty of the clinical enterprise in cardiovascular medicine.
“Shami has been instrumental in the growth of the cardiovascular program at UC San Diego over the past 11 years,” Dillmann said. “He will play a vital role in achieving the full potential of the Sulpizio Cardiovascular Center as a center of excellence in cardiovascular care.”
As a clinician-investigator, Mahmud’s work in both clinical care and research is focused on new and novel approaches to coronary and peripheral vascular interventions. He has extensive experience in complex coronary, renal, lower extremity and carotid interventions.
Under his leadership, the interventional cardiology program at UC San Diego has expanded to be among the largest academic interventional programs in the western United States. He has also helped lead the development and expansion of UC San Diego cardiovascular outreach clinics in Imperial Valley, Encinitas and central San Diego.
After completing an interventional cardiovascular fellowship at Emory University in Atlanta, Mahmud joined the Department of Medicine faculty as Director of the Coronary Care Unit in 2000. He has directed the Cardiovascular Catheterization Laboratories since 2002 and he also founded UC San Diego’s ACGME-accredited interventional cardiology fellowship training program.
For over a decade, Mahmud has directed an active interventional cardiology clinical trials center focusing on investigational antiplatelet/anticoagulant therapies and devices used in cardiovascular interventions. His research is focused on identifying clinical and biochemical factors associated with resistance to antiplatelet therapy. A second area of focus is defining optimal interventional techniques for the treatment of refractory hypertension. A number of medical students, residents and fellows have completed their research projects working in the interventional research unit under his mentorship.
He is among the top 1% of interventional cardiologists in the nation, according to the 2011 “Top Doctors” report from U.S. News & World Report and Castle-Connolly Medical Ltd. Mahmud has been honored on the “San Diego’s Top Doctors” list for the past two years, last year as a Top Doctor in both cardiovascular disease and interventional cardiology. He has also been listed in America’s Top Physicians in Interventional Cardiology from the Consumers’ Research Council of America annually since 2003.
Mahmud will continue to direct the Interventional Cardiology/Cardiovascular Catheterization Laboratories and will oversee both the clinical cardiology training/fellowship programs and the clinical research programs, Dillmann said.
Mahmud is a Fellow of the American College of Cardiology, the Society of Cardiovascular Angiography and Interventions and the Royal College of Physicians and Surgeons of Canada. He serves on the Interventional Scientific Council of the American College of Cardiology and the Know What Counts Public Relations Committee of the Society for Cardiovascular Angiography and Interventions. He is also on the editorial boards of the Journal of the American College of Cardiology, JACC Interventions and Journal of Cardiovascular Diseases.